Home  /  Resource Library  /  Efficacy and safety of the R2-MTX regimen in primary central nervous system lymphoma (PCNSL): a single-center retrospective analysis

Efficacy and safety of the R2-MTX regimen in primary central nervous system lymphoma (PCNSL): a single-center retrospective analysis

Results of a study investigating lenalidomide, rituximab and methotrexate for treatment of PCNSL.